News

Filter

Asthma drug market set to grow $23 billion by 2023

28-11-2014

The asthma treatment market value will grow across eight major countries (the USA, UK, France, Germany,…

AdvairAstraZenecaAustraliaEuropeGlaxoSmithKlineJapanMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySingulairSymbicortUSA

GlaxoSmithKline invests in Australia plant expansion

14-11-2014

UK pharma major GlaxoSmithKline’s Australian subsidiary today announced it will be investing A$31 million…

AustraliaFinancialGlaxoSmithKlinePharmaceuticalProductionRespiratory and PulmonaryVentolin HFA

Back to top